BBNX (Beta Bionics) OCF Yield %: -7.23 (As of Jul. 07, 2026)


BBNX Beta Bionics Inc BBNX
10 GF Score
Price $17.00
! 3 Warning Signs
View Full Analysis

What is Beta Bionics OCF Yield %?

Beta Bionics BBNX +1.71% 10 OCF Yield % is -7.23 as of Jul. 07, 2026. GuruFocus rates BBNX with a GF Score™ of 10/100. The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Beta Bionics ranks worse than 75.26% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Beta Bionics's Trailing 12-Month Cash Flow from Operations is $-54.8 Mil, and Market Cap is $757.5 Mil. Therefore, Beta Bionics's OCF Yield % for today is -7.23%.

The historical rank and industry rank for Beta Bionics's OCF Yield % or its related term are showing as below:

BBNX' s OCF Yield % Range Over the Past 10 Years
Min: -18.43   Med: -8.36   Max: -3.94
Current: -7.23


During the past 4 years, the highest OCF Yield % of Beta Bionics was -3.94%. The lowest was -18.43%. And the median was -8.36%.

BBNX's OCF Yield % is ranked worse than
75.26% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: 1.7 vs BBNX: -7.23

Beta Bionics's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Beta Bionics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Beta Bionics OCF Yield % Related Terms


Beta Bionics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Beta Bionics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beta Bionics OCF Yield % Chart

Beta Bionics Annual Data
Trend Dec22 Dec23 Dec24 Dec25
OCF Yield %
0.00 0.00 0.00 -3.77

Beta Bionics Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -15.06 -8.59 -3.99 -2.55 -21.35

BBNX vs CBLL, SIBN, TCMD: OCF Yield % Comparison

For the Medical Devices subindustry, Beta Bionics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beta Bionics OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beta Bionics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Beta Bionics's OCF Yield % falls into.


BBNX
10GF Score
Beta Bionics Inc BBNX
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beta Bionics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Beta Bionics's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-50.925 / 1351.67967
=-3.77%

Beta Bionics's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-23.832 * 4 / 446.51124
=-21.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -7.23 mean?
Beta Bionics (BBNX) has a OCF Yield % of -7.23 as of Jul. 07, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Beta Bionics and its competitors. According to the industry distribution chart, Beta Bionics ranks #642 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 75.3%.
Is Beta Bionics' OCF Yield % too high?
Beta Bionics' current OCF Yield % is -7.23. Based on the distribution chart, Beta Bionics ranks #642 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beta Bionics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Beta Bionics' OCF Yield % compare to CBLL and SIBN?
According to the Medical Devices & Instruments industry distribution chart, Beta Bionics ranks #642 out of 853 companies for OCF Yield %. This places Beta Bionics in the lower half of its industry. The industry median OCF Yield % is 1.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.70, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Beta Bionics and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beta Bionics's current OCF Yield % is -7.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beta Bionics stock overvalued right now?
Beta Bionics (BBNX) has a current OCF Yield % of -7.23. The current OCF Yield % is -7.23. Beta Bionics' overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Beta Bionics (BBNX), the current OCF Yield % is -7.23 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beta Bionics Business Description

Address 11 Hughes, Irvine, CA, USA, 92618
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
10GF Score

Get the complete analysis for BBNX

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price